Literature DB >> 10631143

Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31.

G Feldman1, M Li, S Martin, M Urbanek, J A Urtizberea, M Fardeau, M LeMerrer, J M Connor, J Triffitt, R Smith, M Muenke, F S Kaplan, E M Shore.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a severely disabling, autosomal-dominant disorder of connective tissue and is characterized by postnatal progressive heterotopic ossification of muscle, tendon, ligament, and fascia and by congenital malformation of the great toes. To identify the chromosomal location of the FOP gene, we conducted a genomewide linkage analysis, using four affected families with a total of 14 informative meioses. Male-to-male transmission of the FOP phenotype excluded X-linked inheritance. Highly polymorphic microsatellite markers covering all human autosomes were amplified by use of PCR. The FOP phenotype is linked to markers located in the 4q27-31 region (LOD score 3.10 at recombination fraction 0). Crossover events localize the putative FOP gene within a 36-cM interval bordered proximally by D4S1625 and distally by D4S2417. This interval contains at least one gene involved in the bone morphogenetic protein-signaling pathway.

Entities:  

Mesh:

Year:  2000        PMID: 10631143      PMCID: PMC1288317          DOI: 10.1086/302724

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  42 in total

Review 1.  The transforming growth factor-beta family.

Authors:  J Massagué
Journal:  Annu Rev Cell Biol       Date:  1990

Review 2.  Fibrodysplasia ossificans progressiva: a clue from the fly?

Authors:  F S Kaplan; J A Tabas; M A Zasloff
Journal:  Calcif Tissue Int       Date:  1990-08       Impact factor: 4.333

3.  The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients.

Authors:  R B Cohen; G V Hahn; J A Tabas; J Peeper; C L Levitz; A Sando; N Sando; M Zasloff; F S Kaplan
Journal:  J Bone Joint Surg Am       Date:  1993-02       Impact factor: 5.284

4.  A three generation family with fibrodysplasia ossificans progressiva.

Authors:  J M Connor; H Skirton; P W Lunt
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

5.  Genetic aspects of fibrodysplasia ossificans progressiva.

Authors:  J M Connor; D A Evans
Journal:  J Med Genet       Date:  1982-02       Impact factor: 6.318

6.  The hand and foot malformations in fibrodysplasia ossificans progressiva.

Authors:  H W Schroeder; M Zasloff
Journal:  Johns Hopkins Med J       Date:  1980-08

7.  Phenotypic and molecular heterogeneity in fibrodysplasia ossificans progressiva.

Authors:  A S Virdi; E M Shore; R O Oreffo; M Li; J M Connor; R Smith; F S Kaplan; J T Triffitt
Journal:  Calcif Tissue Int       Date:  1999-09       Impact factor: 4.333

8.  Genetic transmission of fibrodysplasia ossificans progressiva. Report of a family.

Authors:  F S Kaplan; W McCluskey; G Hahn; J A Tabas; M Muenke; M A Zasloff
Journal:  J Bone Joint Surg Am       Date:  1993-08       Impact factor: 5.284

9.  The histopathology of fibrodysplasia ossificans progressiva. An endochondral process.

Authors:  F S Kaplan; J A Tabas; F H Gannon; G Finkel; G V Hahn; M A Zasloff
Journal:  J Bone Joint Surg Am       Date:  1993-02       Impact factor: 5.284

10.  Novel regulators of bone formation: molecular clones and activities.

Authors:  J M Wozney; V Rosen; A J Celeste; L M Mitsock; M J Whitters; R W Kriz; R M Hewick; E A Wang
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more
  17 in total

1.  Fibrodysplasia ossificans progressiva.

Authors:  L Subramanyam; Kalpana Gowrishankar; So Shivbalan; A Balachandran
Journal:  Indian J Pediatr       Date:  2004-06       Impact factor: 1.967

Review 2.  Heterotopic ossification: a review.

Authors:  E F McCarthy; M Sundaram
Journal:  Skeletal Radiol       Date:  2005-08-25       Impact factor: 2.199

3.  Acceptable outcome following resection of bilateral large popliteal space heterotopic ossification masses in a spinal cord injured patient: a case report.

Authors:  Ramin Espandar; Babak Haghpanah
Journal:  J Orthop Surg Res       Date:  2010-06-22       Impact factor: 2.359

Review 4.  Conserved signaling pathways underlying heterotopic ossification.

Authors:  Chen Kan; Lijun Chen; Yangyang Hu; Na Ding; Haimei Lu; Yuyun Li; John A Kessler; Lixin Kan
Journal:  Bone       Date:  2017-04-25       Impact factor: 4.398

Review 5.  The role of the plain radiograph in the characterisation of soft tissue tumours.

Authors:  Louise Gartner; Christopher J Pearce; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2008-06-20       Impact factor: 2.199

Review 6.  Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP).

Authors:  Eileen M Shore; Frederick S Kaplan
Journal:  Bone       Date:  2008-05-28       Impact factor: 4.398

Review 7.  Animal models of typical heterotopic ossification.

Authors:  Lixin Kan; John A Kessler
Journal:  J Biomed Biotechnol       Date:  2010-10-19

8.  Biological activity of a genetically modified BMP-2 variant with inhibitory activity.

Authors:  Uwe Klammert; Joachim Nickel; Kristian Würzler; Christoph Klingelhöffer; Walter Sebald; Alexander C Kübler; Tobias Reuther
Journal:  Head Face Med       Date:  2009-02-02       Impact factor: 2.151

9.  An unusual case of rapidly progressive contractures: Case report and brief review.

Authors:  R Subasree; Samhita Panda; Pramod Kumar Pal; S Ravishankar
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

10.  Inhibition of extracellular matrix assembly induces the expression of osteogenic markers in skeletal muscle cells by a BMP-2 independent mechanism.

Authors:  Nelson Osses; Juan Carlos Casar; Enrique Brandan
Journal:  BMC Cell Biol       Date:  2009-10-05       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.